These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17168053)

  • 1. Translating epoetin research into practice: the role of government and the use of scientific evidence.
    Lazarus JM; Hakim RM
    Nephrol News Issues; 2006 Dec; 20(13):12, 22. PubMed ID: 17168053
    [No Abstract]   [Full Text] [Related]  

  • 2. Translating epoetin research into practice: the role of government and the use of scientific evidence.
    Cotter D; Thamer M; Narasimhan K; Zhang Y; Bullock K
    Health Aff (Millwood); 2006; 25(5):1249-59. PubMed ID: 16966720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisions in the prescribing information for Epoetin alfa: implications for nephrology nurses and patients on dialysis.
    Hayslip D
    Nephrol Nurs J; 2008; 35(2):163-7. PubMed ID: 18472685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report on epoetin use in oncology is precursor to guidelines.
    Levenson D
    Rep Med Guidel Outcomes Res; 2001 May; 12(11):8-9. PubMed ID: 12148526
    [No Abstract]   [Full Text] [Related]  

  • 5. Improved survival with higher hematocrits: where is the evidence?
    Cotter DJ; Stefanik K; Zhang Y; Thamer M
    Semin Dial; 2004; 17(3):181-3. PubMed ID: 15144538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KDIGO takes clinical practice guidelines to a global level.
    Neumann ME
    Nephrol News Issues; 2006 Nov; 20(12):40-1, 43, 47. PubMed ID: 17125095
    [No Abstract]   [Full Text] [Related]  

  • 7. Anaemia of CKD--the CHOIR study revisited.
    Singh AK; Szczech L; Tang KL; Barnhart H; Sapp S; Wolfson M; Reddan D
    Nephrol Dial Transplant; 2007 Jul; 22(7):1806-10. PubMed ID: 17420166
    [No Abstract]   [Full Text] [Related]  

  • 8. Current and future challenges in anaemia management.
    Levin A; Locatelli F; Muirhead N; Ritz E
    Nephrol Dial Transplant; 2005 Jun; 20 Suppl 6():vi1-2. PubMed ID: 15958819
    [No Abstract]   [Full Text] [Related]  

  • 9. Is it time to reconsider subcutaneous administration of epoetin?
    Patel TV; Robinson K; Singh AK
    Nephrol News Issues; 2007 Oct; 21(11):57, 59, 63-4 passim. PubMed ID: 17970510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Has economics overshadowed our clinical approaches to EPO?
    Sullivan JD
    Nephrol News Issues; 2007 Jul; 21(8):56, 58-9, 68. PubMed ID: 17688233
    [No Abstract]   [Full Text] [Related]  

  • 11. Anemia and response to epoetin alfa: the cause of anemia matters!
    Dharmarajan TS
    J Am Geriatr Soc; 2008 Aug; 56(8):1574-5. PubMed ID: 18808607
    [No Abstract]   [Full Text] [Related]  

  • 12. Epoetin alfa: biosimilar. Copied, with biosimilar status.
    Prescrire Int; 2009 Feb; 18(99):16-7. PubMed ID: 19391233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lesson from the EPO mess: stop the cost shifting.
    Amerling R
    Nephrol News Issues; 2007 Jul; 21(8):52, 54-5, 68. PubMed ID: 17688232
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical practice guidelines in nephrology--for worse or for better.
    Uhlig K; Balk EM; Lau J; Levey AS
    Nephrol Dial Transplant; 2006 May; 21(5):1145-53. PubMed ID: 16520349
    [No Abstract]   [Full Text] [Related]  

  • 15. Epoetin trials: randomised controlled trials don't always mimic observational data.
    Roger SD; Levin A
    Nephrol Dial Transplant; 2007 Mar; 22(3):684-6. PubMed ID: 17210590
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to the publication: EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.
    Gascón P; Ludwig H
    Eur J Cancer; 2005 Dec; 41(18):2789-91. PubMed ID: 16253500
    [No Abstract]   [Full Text] [Related]  

  • 17. Dialysis facility ownership and epoetin dosing in hemodialysis patients: a US physician perspective.
    Kasiske BL
    Am J Kidney Dis; 2007 Sep; 50(3):354-7. PubMed ID: 17720512
    [No Abstract]   [Full Text] [Related]  

  • 18. Creating a better environment to treat anemia in patients with CKD.
    Sinnen MT
    Nephrol Nurs J; 2007; 34(6):645-9. PubMed ID: 18203573
    [No Abstract]   [Full Text] [Related]  

  • 19. NRAA responds to proposed $1 cut in EPO reimbursement.
    Nephrol News Issues; 1998 Apr; 12(4):12-3. PubMed ID: 9601363
    [No Abstract]   [Full Text] [Related]  

  • 20. Updating practices in an evolving IV iron and anemia environment: practical solutions.
    Amerling R; Easom A; Juergensen P
    Nephrol Nurs J; 2007; 34(5):533-41; quiz 542-3. PubMed ID: 18041456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.